Mitosol is a system for delivering antifibrotic agents in glaucoma, refractive and corneal surgery, though the refractive and corneal indications are awaiting approval by the FDA.
Related Articles on Ophthalmology:
Pioneering Ophthalmologist Dr. Robert C. Welsh Dies at Age 89
Dr. Alan Faulkner Now Offering LenSx Femtosecond Laser at his Hawaii Cataract Surgery Practice
Dr. Ruth D. Williams Begins Term as President of the American Academy of Ophthalmology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.